医学论文-乳癌术后方对乳腺癌术后5年复发转移率的影响.docVIP

医学论文-乳癌术后方对乳腺癌术后5年复发转移率的影响.doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
医学论文-乳癌术后方对乳腺癌术后5年复发转移率的影响

医学论文-乳癌术后方对乳腺癌术后5年复发转移率的影响 【摘要】? 观察乳癌术后方对乳腺癌术后患者5年复发转移率的影响。方法:将300例乳腺癌术后患者分为治疗组和对照组,治疗组在西医治疗的同时服用乳癌术后方,对照组采用相同的西医治疗。随访5年,观察乳癌术后方对乳腺癌术后患者5年复发转移率的影响。 结果:除34例因失访而脱落外,对完成5年随访的266例患者进行疗效评价。治疗组5年复发转移率低于对照组(P<0.05)。患者的淋巴结转移数量、原发肿瘤大小、临床分期及受体状态对乳腺癌术后的复发转移有影响。腋窝淋巴结转移≥4个,原发肿瘤直径>2 cm,临床Ⅱ期和Ⅲ期,雌激素受体(estrogen receptor, ER)(+)孕激素受体(progesterone receptor, PR)(+)和ER(-)PR(-)的患者,治疗组复发转移率明显低于对照组(P<0.05);腋窝淋巴结转移<4个、原发肿瘤最大直径≤2 cm、临床分期Ⅰ期以及ER(+)PR(-)和ER(-)PR(+)的患者,两组复发转移率比较,差异无统计学意义(P>0.05)。手术方式和年龄对乳腺癌术后的复发转移无明显影响。结论:乳癌术后方能降低乳腺癌术后患者5年复发转移率。 【关键词】? 乳腺癌 复发 转移 乳癌术后方 中医学 ??? Methods: A total of 300 patients with breast cancer were divided into two groups: treatment group and control group. The patients in the treatment group were treated with Western medicine and RSR, and the patients in the control group were treated only with Western medicine (the same as the treatment group). In the two groups, the 5year recurrence rates after mastectomy in breast cancer were investigated. ??? Results: Thirtyfour breast cancer patients were lost to fiveyear followup during the course of investigation, and 266 breast cancer patients went through the evaluation. The 5year recurrence rate after mastectomy in the treatment group was significantly lower than that in the control group (P0.05). The recurrence rate after mastectomy was influenced by positive lymph node, primary breast tumor size, clinical stage, and patients health status. There was significant difference in the 5year recurrence rates between the two groups (P0.05) under the following conditions, such as the positive lymph nodes more than four, the primary breast tumor larger than two centimeters, and in the clinical stage Ⅱ and Ⅲ, estrogen receptor (ER)positive/progesterone receptor (PR)positive and ERnegative/PRnegative. The recurrence rate was not associated with the operation method and age distribution. ??? Conclusion: RSR can reduce the 5year recurrence rate after mastectomy in breast cancer. ??? Keywords: breast cancer; recurrence

文档评论(0)

xcs88858 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:8130065136000003

1亿VIP精品文档

相关文档